ClinAssess Gesellschaft für klinische Forschung mbH
Industry / private company
Location:
Leverkusen,
Germany (DE)
ISNI: -
A Randomized Phase II Trial Comparing the Efficacy and Safety of Pioglitazone, Clarithromycin and Metronomic Low-Dose Chemotherapy with Single-Agent Nivolumab Therapy in Patients with Advanced Non-small Cell Lung Cancer Treated in Second or Further Line (ModuLung) (2021)
Heudobler D, Schulz C, Fischer JR, Staib P, Wehler T, Suedhoff T, Schichtl T, et al.
Journal article
Kinetics of renal function during induction in newly diagnosed multiple myeloma: Results of two prospective studies by the german myeloma study group dsmm (2021)
Bachmann F, Schreder M, Engelhardt M, Langer C, Wolleschak D, Muegge LO, Duerk H, et al.
Journal article
Lenalidomide, adriamycin, dexamethasone (RAD) for induction followed by stem-cell transplant in newly diagnosed myeloma (2017)
Knop S, Langer C, Engelhardt M, Muegge LO, Reichle A, Rösler W, Bassermann F, et al.
Journal article